SUMMARY
The Fund rose 2.5% (in AUD) and 2.4% (in USD) in the month of September. By comparison, the Tel Aviv Stock Exchange 125 Index and the Tel Aviv Stock Exchange Small And Medium Cap 60 Index rose 2.3% and 4.2% respectively. This strong performance was in the face of falling global equity markets that struggled due to rising inflationary concerns, the likelihood of higher interest rates, and the implications for economic growth.
The upward trends in the Banking and Real Estate sectors continued during September, creating a headwind for the Fund’s relative performance. Pleasingly however the Fund’s two biggest positions, Priortech and Ilex Medical, both performed well and contributed significantly. Both of these companies have been discussed in detail in prior monthly newsletters.